News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cambria Biosciences Awarded Three Small Business Innovation Research Grants From National Institutes of Health (NIH) For Company's Neurodegenerative Disease Program



10/19/2005 5:12:41 PM

WOBURN, Mass.--(BUSINESS WIRE)--Feb. 11, 2005--Cambria Biosciences LLC, a drug discovery company, today announced that it has been awarded three new Phase I Small Business Innovation Research (SBIR) grants totaling more than $700,000 from the National Institutes of Health to support the company's drug discovery program for neurodegenerative diseases.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES